Review
Open access
2026
Cardiovascular outcomes and safety of chlorthalidone versus hydrochlorothiazide: A systematic review and meta-analysis
CTD does not provide superior cardiovascular or renal protection compared with HCTZ, and HCTZ remains a pragmatic first-line option in hypertension.
L. Choonara, M. Vally
· SA Heart · 0 citations